Presage Biosciences Closes Series D Financing with Takeda and Celgene, and Announces Appointment of Richard Klinghoffer, PhD as Chief Executive Officer

VIEW ARTICLE
If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.